CU23668A3 - ANTIBODIES DIRECTED AGAINST THE BETA-AMYLOID PEPTIDE AND METHODS OF USING THE SAME - Google Patents
ANTIBODIES DIRECTED AGAINST THE BETA-AMYLOID PEPTIDE AND METHODS OF USING THE SAMEInfo
- Publication number
- CU23668A3 CU23668A3 CU20070029A CU20070029A CU23668A3 CU 23668 A3 CU23668 A3 CU 23668A3 CU 20070029 A CU20070029 A CU 20070029A CU 20070029 A CU20070029 A CU 20070029A CU 23668 A3 CU23668 A3 CU 23668A3
- Authority
- CU
- Cuba
- Prior art keywords
- beta
- directed against
- antibodies directed
- methods
- same
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 4
- 102000013455 Amyloid beta-Peptides Human genes 0.000 abstract 2
- 108010090849 Amyloid beta-Peptides Proteins 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000012636 effector Substances 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Se describen un anticuerpo monoclonal 9TL y anticuerpos obtenidos de 9TL dirigidos contra péptidos beta-amiloide y procedimiento para usar los mismos para el diagnóstico y tratamiento de la enfermedad de Alzheimer y enfermedades asociadas al péptido Aß. También se descrben procedimientos para usar anticuerpos dirigidos contra péptido amiloide-beta que tiene la funciónefectora alterada para el tratamiento de la enfermedad de Alzheimer y enfermedades asociada a péptido Aß.A 9TL monoclonal antibody and 9TL antibodies directed against beta-amyloid peptides and method for using them for the diagnosis and treatment of Alzheimer's disease and diseases associated with the Aβ peptide are described. Methods for using antibodies directed against amyloid-beta peptide having the impaired effector function for the treatment of Alzheimer's disease and diseases associated with Aβ peptide are also described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070029A CU23668A3 (en) | 2007-01-30 | 2007-01-30 | ANTIBODIES DIRECTED AGAINST THE BETA-AMYLOID PEPTIDE AND METHODS OF USING THE SAME |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070029A CU23668A3 (en) | 2007-01-30 | 2007-01-30 | ANTIBODIES DIRECTED AGAINST THE BETA-AMYLOID PEPTIDE AND METHODS OF USING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23668A3 true CU23668A3 (en) | 2011-05-27 |
Family
ID=44306242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20070029A CU23668A3 (en) | 2007-01-30 | 2007-01-30 | ANTIBODIES DIRECTED AGAINST THE BETA-AMYLOID PEPTIDE AND METHODS OF USING THE SAME |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23668A3 (en) |
-
2007
- 2007-01-30 CU CU20070029A patent/CU23668A3/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI200700021A (en) | DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME. PC19496A | |
| TW200718710A (en) | Antibodies directed against amyloid-beta peptide and methods using same | |
| BR0310088A (en) | Drug pre-targeting by bispecific antibodies and haptenic constructs comprising a peptide vehicle and the active agent (s) | |
| WO2005018424A3 (en) | Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits | |
| UY29282A1 (en) | HUMANIZED ANTIBODIES RECOGNIZING THE BETA AMYLOID PEPTIDE | |
| BRPI0415230A (en) | bispecific antibody replacement for functional proteins | |
| MXPA05012718A (en) | Humanized antibodies that recognize beta amyloid peptide. | |
| AR051800A1 (en) | BETA ANTIBODIES USED TO IMPROVE COGNITION | |
| CR9512A (en) | METHODS FOR THE TREATMENT OF BRAIN TUMORS WITH ANTIBODIES | |
| DOP2021000199A (en) | ANTIBODIES AGAINST AMYLOID-ß WITH PYROGLUTAMATE AND THEIR USES | |
| MY139983A (en) | Humanized antibodies that recognize beta amyloid peptide | |
| BRPI0314814B8 (en) | antibody comprising a variant of fc | |
| AR047729A1 (en) | THERAPEUTIC ANTIBODIES THAT BIND APOLIPOPROTEIN E (APOE) | |
| CY1110963T1 (en) | HUMANITIZED ANTIBODIES RECOGNIZING BETA AMYLOID Peptide | |
| PE20061040A1 (en) | HUMANIZED ANTIAMYLLOID ANTIBODIES | |
| EA201590833A1 (en) | ANTIBODIES FOR THE TREATMENT AND PREVENTION OF THE ALZGEIMER'S DISEASE AND THEIR APPLICATION | |
| PE20110797A1 (en) | ANTI MN ANTIBODIES | |
| NO20060843L (en) | RG1 antibodies and uses thereof | |
| BRPI0414513A (en) | kid3 and kid3 antibodies that bind to it | |
| MX2011012677A (en) | Albumin-amyloid peptide conjugates and uses thereof. | |
| CU23668A3 (en) | ANTIBODIES DIRECTED AGAINST THE BETA-AMYLOID PEPTIDE AND METHODS OF USING THE SAME | |
| AR055072A1 (en) | USE OF ANTI-MADCAM ANTIBODIES FOR THE TREATMENT OF CELIAC DISEASE AND TROPICAL ESPRUE | |
| SE0302422D0 (en) | Peptide-based immunization therapy for the treatment of atherosclerosis | |
| CR8883A (en) | DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME | |
| WO2009120659A3 (en) | Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |